Renalytix plc, a company that uses artificial intelligence to diagnose and treat kidney disease, has announced that it is considering selling itself or its assets after receiving an unsolicited takeover offer from a larger competitor. The company, which is listed on both the London Stock Exchange and the Nasdaq, said that it has launched a…
All posts tagged Renalytix
St. Joseph’s Health and Renalytix partner to advance kidney health in New York
NEW YORK: St. Joseph’s Health and Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced a partnership to implement an advanced clinical care model designed to improve kidney health in patients with type 2 diabetes and early-stage chronic kidney disease. The Renalytix KidneyIntelX platform will be integrated with St. Joseph’s Health care management to help prevent patients with diabetes…